Yasue Niwa

Tatsuno, 6795165, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Endovascular pulmonary arterial fiducial marker placement for particle radiotherapy using proton or carbon-ion beams for lung cancer.

Endovascular pulmonary arterial fiducial marker placement for particle radiotherapy using proton or carbon-ion beams for lung cancer.

Journal: Journal of radiation research

Published: December 08, 2025

Protective Effect of Polaprezinc and Hyperbaric Oxygen Therapy on Radiation-induced Small Intestinal Damage in Mice.

Protective Effect of Polaprezinc and Hyperbaric Oxygen Therapy on Radiation-induced Small Intestinal Damage in Mice.

Journal: In vivo (Athens, Greece)

Published: July 22, 2022

Proton Therapy for Localized Prostate Cancer: Long-Term Results From a Single-Center Experience.

Proton Therapy for Localized Prostate Cancer: Long-Term Results From a Single-Center Experience.

Journal: International journal of radiation oncology, biology, physics

Published: June 29, 2020

Treatment outcomes of proton or carbon ion therapy for skull base chordoma: a retrospective study.

Treatment outcomes of proton or carbon ion therapy for skull base chordoma: a retrospective study.

Journal: Radiation oncology (London, England)

Published: September 07, 2018

Long-term outcomes in patients treated with proton therapy for localized prostate cancer.

Long-term outcomes in patients treated with proton therapy for localized prostate cancer.

Journal: Cancer medicine

Published: January 25, 2017

Polaprezinc protects normal intestinal epithelium against exposure to ionizing radiation in mice.

Polaprezinc protects normal intestinal epithelium against exposure to ionizing radiation in mice.

Journal: Molecular and clinical oncology

Published: February 01, 2016

The threshold of hypothyroidism after radiation therapy for head and neck cancer: a retrospective analysis of 116 cases.

The threshold of hypothyroidism after radiation therapy for head and neck cancer: a retrospective analysis of 116 cases.

Journal: Journal of radiation research

Published: November 30, 2014

Particle therapy for clinically diagnosed stage I lung cancer: comparison with pathologically proven non-small cell lung cancer.

Particle therapy for clinically diagnosed stage I lung cancer: comparison with pathologically proven non-small cell lung cancer.

Journal: Acta oncologica (Stockholm, Sweden)

Published: November 11, 2014

Polaprezinc reduces the severity of radiation-induced mucositis in head and neck cancer patients.

Polaprezinc reduces the severity of radiation-induced mucositis in head and neck cancer patients.

Journal: Molecular and clinical oncology

Published: September 16, 2014

Treatment outcomes of particle radiotherapy using protons or carbon ions as a single-modality therapy for adenoid cystic carcinoma of the head and neck.

Treatment outcomes of particle radiotherapy using protons or carbon ions as a single-modality therapy for adenoid cystic carcinoma of the head and neck.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: May 25, 2014

Arterial chemoradiotherapy for carcinomas of the external auditory canal and middle ear.

Arterial chemoradiotherapy for carcinomas of the external auditory canal and middle ear.

Journal: The Laryngoscope

Published: February 27, 2014

Particle beam radiation therapy using carbon ions and protons for oligometastatic lung tumors.

Particle beam radiation therapy using carbon ions and protons for oligometastatic lung tumors.

Journal: Radiation oncology (London, England)

Published: February 24, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026